1Tsuda H, Takarabe T, Hasegawa T, et ol. Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones[J]. Hum Pathol, 1999, 30(10): 1134- 1139.
2Perou CM, Sorlie T, Eisen MB, et ol. Molecular portraits of human breast tumours[J]. Nature, 2000, 406(6797) : 747 - 752.
3Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patternsof breast carcinomas distinguish tumor subclasses with clinical implications[J]. Proc Nad Acad Sci USA, 2001, 98(19): 10869- 10874.
4Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets[J]. Proc Natl Acad Sci USA, 2003, 100(14): 8418-8423.
5Sotifiou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study[J]. Proc Natl Acad Sol USA, 2003, 100 (18) : 10393 - 10398.
6Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J]. Clin Cancer Res, 2004, 10(16): 5367-5374.
7Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J]. Clin Cancer Res, 2004, 10(16): 5367-5374.
8Laakso M, Loman N, Borg A, et al. Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCAI tuners[J]. Mod Pathol, 2005, 18(10): 1321 - 1328.
9Matos I, Dufloth R, Alvarenga M, et al. p63, cytokeratin 5, and P- cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas[J]. Virchows Arch, 2005, 447(4): 688- 694.
10Fulford LG, Easton DF, Reis-Filho JS, et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast[J]. Histopathology, 2006, 49( 1 ) : 22 - 34.
